ID: MRFR/Pharma/8279-HCR | 140 Pages | Published By Rahul Gotadki on March 2023
HIV Diagnostics Market is expected to hold a value of about USD 7,118.26 Million by 2030 and is projected to register a CAGR of 9.20% from 2023 to 2030.
$4.1 Billion
9.20%
North America
2023 to 2030
HIV diagnostics market is expected to reach USD 4.1 Billion by 2030 and is projected to register a CAGR of 9.20% from 2023 to 2030.
Human immunodeficiency virus (HIV) is an autoimmune disease which affects the immune system similar to other autoimmune diseases and leaves the body susceptible to other diseases and infections. HIV diagnostics are majorly used to test the HIV diseases.
There are large number of different market player for HIV diagnostics that dominates the HIV diagnostics market, which includes Siemens Healthiness, Roche Diagnostics, Abbott Laboratories, Beckman Coulter, Inc. and many more. The companies are involved in launching new products, technologies, and are undergo strategic collaboration to develop healthcare produces. For instance, on January 2019, Hologic Inc. has received US Food and Drug Administration (FDA) for its Aptima Mycoplasma genitalium assay, used to detect common sexually transmitted infection (STI).
HIV Diagnostics Market Influencer
The increasing innovation and research activity to develop innovative HIV diagnostic kits boosts the market growth.
Market Drivers
Market Restraints
HIV Diagnostics Market Segmentation
By Product
By Test Type
By End-User
By Region
HIV Diagnostics Market Key Players
Report Attribute/Metric | Details |
---|---|
Market Size | 2027: USD 7,118.26 Million |
CAGR | 10.6% (2020-2027) |
Base Year | 2019 |
Forecast Period | 2027 |
Historical Data | 2018 |
Forecast Units | Value (USD Million) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | By Product, Test Type, End User and Region |
Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
Key Vendors | Siemens Healthineers (A Division of Siemens AG) (Erlangen, Germany.), Roche Diagnostics (Division of Hoffman La Roche Ltd.) (Basel, Switzerland), Abbott Laboratories (Chicago, US), Beckman Coulter, Inc. (Subsidiary of Danaher Corporation) (California, US), Thermo-Fisher Scientific Inc. (Massachusetts, US), Merck KGaA (Darmstadt, Germany), Becton, Dickinson & Company (New Jersey, US), Hologic Inc. (Massachusetts, US), Alere Inc. (Massachusetts, US), Bio-Rad Laboratorie (California, US) |
Key Market Opportunities | The increasing innovation and research activity to develop innovative HIV diagnostic kits boosts the market growth. |
Key Market Drivers | Growing prevalence of HIV/Aids across the globe. According to The Joint United Nations Programme on HIV/AIDS (UNAIDS) there were approximately 37.9 million people across the globe with HIV/AIDS in 2018. |
The market value by 2030 can be USD 4.1 Billion, says MRFR.
The market can record a CAGR of 9.20% from 2023 to 2030.
Siemens Healthineers (A Division of Siemens AG) (Erlangen, Germany.), Roche Diagnostics (Division of Hoffman La Roche Ltd.) (Basel, Switzerland), Abbott Laboratories (Chicago, US), Beckman Coulter, Inc. (Subsidiary of Danaher Corporation) (California, US), Thermo-Fisher Scientific
Lack of technological and developmental innovations across low middle-income economies can be a key market restraint.
Consumables segment is the fastest growing in the global market.
The leading firms are adopting growth strategies such as new product launches, technological innovations, and collaborations and partnerships.